CVI Track the topics, authors and articles important to you
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00359-07v1
15/3/579    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Melo Cardoso Almeida, C.
Right arrow Articles by Junqueira-Kipnis, A. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melo Cardoso Almeida, C.
Right arrow Articles by Junqueira-Kipnis, A. P.
Clinical and Vaccine Immunology, March 2008, p. 579-581, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00359-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Humoral Immune Responses of Tuberculosis Patients in Brazil Indicate Recognition of Mycobacterium tuberculosis MPT-51 and GlcB{triangledown}

Cristina Melo Cardoso Almeida,1 Arioldo C. Vasconcelos Jr.,1 André Kipnis,2 Ana Lúcia Andrade,3 and Ana Paula Junqueira-Kipnis1*

Departamento de Microbiologia, Imunologia, Parasitologia e Patologia, Laboratório de Imunopatologia das Doenças Infecciosas,1 Laboratório de Bacteriologia Molecular,2 Departamento de Saúde Coletiva, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia-Go, Brasil3

Received 3 September 2007/ Returned for modification 2 October 2007/ Accepted 8 January 2008

The humoral responses to recombinant MPT-51 and GlcB was determined by using an enzyme-linked immunosorbent assay. Levels of immunoglobulin M (IgM) against MPT-51 and IgG against GlcB were higher among tuberculosis (TB) patients than among control individuals. When the MPT-51 and GlcB assays were combined, 90.8% specificity and 75.5% sensitivity were observed. MPT-51 and GlcB were recognized in the humoral responses of Brazilian TB patients.

* Corresponding author. Mailing address: Rua Delenda Rezende de Melo S/N, Setor Universitário, 74605-050 Goiânia-Goiás, Brazil. Phone: 55 11 62 32096126. Fax: 55 11 62 35211839. E-mail: anapaula{at}iptsp.ufg.br

{triangledown} Published ahead of print on 16 January 2008.

Clinical and Vaccine Immunology, March 2008, p. 579-581, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00359-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.